Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
about
Real-time analysis of the effects of toxic, therapeutic and sub-therapeutic concentrations of digitoxin on lung cancer cellsCancer stem cells and signaling pathways in radioresistanceProstate cancer relevant antigens and enzymes for targeted drug deliveryKnockdown of EpCAM enhances the chemosensitivity of breast cancer cells to 5-fluorouracil by downregulating the antiapoptotic factor Bcl-2Clinical implication of CD166 expression in salivary gland tumor.Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAMPiwil2 modulates the invasion and metastasis of prostate cancer by regulating the expression of matrix metalloproteinase-9 and epithelial-mesenchymal transitions.MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasisAlpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells.Xtalk: a path-based approach for identifying crosstalk between signaling pathwaysPrimary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines.AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma PatientsHigh expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis.Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.Establishing guidelines for CAR-T cells: challenges and considerations.MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.Inhibition of mTOR enhances radiosensitivity of lung cancer cells and protects normal lung cells against radiation.EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway.PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.Tpl2 induces castration resistant prostate cancer progression and metastasis.Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis.Allicin inhibits the invasion of lung adenocarcinoma cells by altering tissue inhibitor of metalloproteinase/matrix metalloproteinase balance via reducing the activity of phosphoinositide 3-kinase/AKT signaling.The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer.Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.Paeonol enhances the sensitivity of human ovarian cancer cells to radiotherapy-induced apoptosis due to downregulation of the phosphatidylinositol-3-kinase/Akt/phosphatase and tensin homolog pathway and inhibition of vascular endothelial growth factRegulatory effects of COL1A1 on apoptosis induced by radiation in cervical cancer cells.Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor.Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients.Radiation-Induced Changes of microRNA Expression Profiles in Radiosensitive and Radioresistant Leukemia Cell Lines with Different Levels of Chromosome Abnormalities.Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer.Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
P2860
Q23919744-BB83B760-3172-4FD0-A995-5257AF2ADB1EQ26771576-9071ADC4-165A-45FE-B6E7-9048F21586B6Q27013843-DE4306A4-CBA1-4623-8623-062B8271690AQ28540713-49F964A3-1C9C-42DB-B42B-30CCE49317E4Q35486869-EA75B0B0-FEC3-4905-97F9-85EB73AA00F1Q35552124-291906C8-9CDC-4CE0-9DC4-52ED9CE0D5D7Q35943167-881EBFE5-B1DD-4AA1-824F-65AE28E11050Q36401886-E5889393-814B-479D-867B-B392E2AC45D1Q36413078-B1EACF08-D30B-4DC8-9001-7F4D2369FAABQ36413730-79C98A09-72FE-4295-8D23-4BB9B99ED37CQ36595263-6E8B1CB7-7688-4B2D-890A-ECC056FB04DBQ37002991-B9DD885C-1A07-4CBA-A56A-7D6B10B3AF1AQ37301718-D6CB5441-8F06-45FD-A1C6-6E2D66688AC4Q37427945-E2B44537-E294-4A22-9FCD-E291BB57BBEBQ37580321-DBF12C54-C2D1-43EA-9A38-9725DD0CBC4BQ37657753-B6E4B515-8AAE-4485-83F2-34D67F0DCD0DQ37728684-16BD2D07-6CED-4BDA-9081-B9DA52321726Q38206587-0272A715-4C27-420E-B465-D6C0FD238D62Q38618544-426AA89C-B6D5-4966-A6C9-61D6B390939DQ38693785-AEB82C15-DE5C-4269-892A-77BA5409B6BFQ38769264-11FBA83A-A22F-4823-B030-E0085B50FCFEQ38782227-3DCFCA09-6D78-4A45-A7CB-1DEF7F48BE64Q38784466-E88BD278-F8C7-40C0-97B8-336BE5DD8A0DQ38818910-57E6A950-8589-45FA-8A48-BB3265926CB5Q38824756-36AA09B8-9547-4CA3-9CDB-683189FC6D44Q38951260-5AF32A0C-811B-4E0F-9B2C-F8C6B90AEE09Q38951496-6982F340-6044-4092-8249-82A1438A1221Q38958021-5D49782F-2F10-492A-8D6F-1079606BBE69Q38978361-4413B32B-B18C-447F-9CBF-A9A0D90FC9ACQ39424549-04FF0C2C-AB81-4163-AFCC-6AD8A9433E60Q40978616-C0554FD0-48A9-4B06-9C8C-38BD4DE889B1Q41279960-A920ED0F-23C4-4ECA-BE2F-5EDA4C0B5672Q41324942-B92D11BF-4F78-4C36-A979-C9AF022E5293Q41623770-8BDB6400-D5E5-41D7-9827-E187D6795589Q42339319-0E4EC138-2519-4879-9141-F2C3C6D0FD7CQ45840119-CA10E5E4-CFFE-4C72-8E31-AEC41DCC37C3Q47097853-0009DFE2-86C5-40F1-B505-8BB246F4A267Q47130047-99F45B65-490A-467B-AF6F-9B5D38BE69F2Q47172196-8A5FFEAC-7F9C-4EDE-9B00-9DF568F8982FQ47203446-BDE1936F-74CB-44B1-8119-E01C11C71A56
P2860
Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Epithelial cell adhesion molec ...... 3K/Akt/mTOR signaling pathway.
@ast
Epithelial cell adhesion molec ...... 3K/Akt/mTOR signaling pathway.
@en
type
label
Epithelial cell adhesion molec ...... 3K/Akt/mTOR signaling pathway.
@ast
Epithelial cell adhesion molec ...... 3K/Akt/mTOR signaling pathway.
@en
prefLabel
Epithelial cell adhesion molec ...... 3K/Akt/mTOR signaling pathway.
@ast
Epithelial cell adhesion molec ...... 3K/Akt/mTOR signaling pathway.
@en
P2093
P1476
Epithelial cell adhesion molec ...... 3K/Akt/mTOR signaling pathway.
@en
P2093
Jingli Hao
John Kearsley
Joseph Bucci
Julia Beretov
Paul Cozzi
Peter Graham
Sarah Shigdar
Warick Delprado
P304
P356
10.1016/J.BIOCEL.2013.09.008
P577
2013-09-25T00:00:00Z